Skip to main content

Press Releases View all 12 hits

Cavidi Selected to Present at Cavendish Global Health Impact Forum
EIB supports Cavidi’s development of HIV viral load monitoring device
Cavidi introduces Ziva™ – a breakthrough in near-patient viral load monitoring
Investment with Impact: Closing the HIV treatment gap

Investment with Impact: Closing the HIV treatment gap

Press Releases   •   May 09, 2014 09:38 GMT

A presentation on the importance of global viral load monitoring to contain the HIV pandemic.

News View all 31 hits

Cavidi secures ALMI grant to expand presence in US market

Cavidi secures ALMI grant to expand presence in US market

News   •   May 22, 2018 07:56 GMT

Cavidi has been granted matching funds to develop a US market strategy in the research area of viral vectors used to transfect genes in next-generation clinical applications such a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). Applications include quantified potency assessment of viral vectors used in emerging vaccines and gene therapies to treat a wide range of diseases.

Cavidi finalists in Uppsala Innovation Award 2018

Cavidi finalists in Uppsala Innovation Award 2018

News   •   Apr 21, 2018 13:21 GMT

Cavidi were proud to be nominated as a finalist for the Innovation Award for the Uppsala region among all companies. http://foretagargalanuppsala.se/hem/finalister2018/

Cavidi with new financial strength is getting ready to fill an important gap in the global fight against HIV
Cavidi at ASLM2016

Cavidi at ASLM2016

News   •   Dec 02, 2016 10:56 GMT

Blog posts 4 hits

World Aids Day 2013: Halfway to Zero

World Aids Day 2013: Halfway to Zero

Blog posts   •   Nov 28, 2013 09:50 GMT

Each year World Aids Day helps raise awareness around the world. It’s also a time for everyone involved in the fight against HIV to step back and assess our progress. Looking at the HIV community as a whole and Cavidi in particular, I can say it’s been a good year overall. We have seen great progress in the treatment of HIV worldwide.

Media no image

Could RT technology help close the EID gap?

Blog posts   •   Jul 23, 2012 10:30 GMT

There are around 370,000 new infant infections worldwide each year. A significant number of these children will die if they are not diagnosed early and started on antiretroviral drugs (ARVs). The problem is not the lack of ARVs as much as a lack of proper HIV early infant diagnostics (EID). Recent reports indicate that RT-technology may be an answer to improved access to (EID).

The HIV Subtype Picture

The HIV Subtype Picture

Blog posts   •   Oct 13, 2011 08:52 GMT

Although the North American and Western European experience has historically been with HIV-1 group M subtype B virus, this is changing rapidly as migrants and refugees from developing countries with non-B subtype infections now present for care in the developed world, and travelers to developing countries acquire non-B subtype infection abroad and present for care at home.

Three reasons HIV viral load monitoring matters

Three reasons HIV viral load monitoring matters

Blog posts   •   Sep 15, 2011 08:07 GMT

Measuring an individual’s HIV viral load provides healthcare professionals with an accurate picture of viral activity. This is a powerful tool in fighting the HIV pandemic for three reasons:

Images View all 5 hits

Cavidi board members

Cavidi board members

License Creative Commons Attribution
Download
Size

7.96 MB • 4800 x 3200 px

HIV treatment scale-up and new WHO ARV guidelines 2013

HIV treatment scale-up an...

GENEVA - New HIV treatment guidelines by WHO recommend offering antiretroviral therapy (ART) earlier. Recent evidence indicates that earl...

License Creative Commons Attribution
Download
Size

254 KB • 893 x 600 px

SWECARE Export Award 2102

SWECARE Export Award 2102

License Creative Commons Attribution
Download
Size

197 KB • 600 x 800 px

SWECARE Export Award 2102

SWECARE Export Award 2102

The Swecare Export Award is to encourage and highlight successful Swedish companies and create good examples of successful export venture...

License Creative Commons Attribution
Download
Size

27.3 KB • 364 x 194 px

Videos 3 hits

Cavidi innovation

Cavidi innovation

Cavidi's innovation is aimed at closing the gap betweenr the market need for Viral Load and current capabilities for decentralised testin...

License Creative Commons Attribution
Download
Size

640 x 360 px

Cavendish Global Health Impact Forum - John Reisky, Cavidi CEO

Cavendish Global Health I...

Cavidi CEO, John Reisky de Dubnic, presents a solution to help close a major treatment gap in the global effort to contain the Human Immu...

License Creative Commons Attribution
Download
Size

88.5 MB • 642 x 360 px

CNN airs segment on Cavidi efforts to expand HIV care accessibility

CNN airs segment on Cavid...

Atlanta – CNN broadcasted a feature piece on Cavidi’s ExaVir Load HIV viral load assay. The story centered on Cavidi’s mission to make es...

License Creative Commons Attribution
Download
Size

4.23 MB • 320 x 240 px

Documents 3 hits

MSF report on the development needs in HIV viral load monitoring access

Routine use of viral load testing makes business sense: it will save money on drugs with effective monitoring of patients. MSF identifies the needs of a solution in a wish list on p23. This is the market opportunity that Cavidi is seeking to address with our new platform meeting requirements that MSF have identified for laboratory-based tests. Cavidi ref on p 5,20,21,23,30,and 31.

14 Key concepts for HIV

14 Key concepts for HIV

Documents   •   Jun 12, 2012 19:34 GMT

ExaVir Load Datasheet

ExaVir Load Datasheet

Documents   •   Nov 01, 2011 13:44 GMT